DEBORHA CAPUTO: Open Payments
NPI 1508939281 · POMONA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,167 in 56 payments from 13 companies in 2025. Trend: 2023 $1,898 · 2024 $1,694 · 2025 $2,167
Food & beverage: $2,068Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $576 |
| Janssen Biotech, Inc. | 5 | $554 |
| QOL Medical, LLC | 2 | $159 |
| Madrigal Pharmaceuticals | 1 | $146 |
| Intercept Pharmaceuticals, Inc. | 2 | $139 |
| Ardelyx, Inc. | 1 | $125 |
| Lilly USA, LLC | 1 | $121 |
| Gilead Sciences, Inc. | 5 | $107 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
Products named: TREMFYA, RINVOQ, SKYRIZI, Sucraid, REZDIFFRA, OCALIVA, IBSRELA, OMVOH.
Industry payments across NY — which companies pay providers there.
